LEARNING ENGLISH LANGUAGE FROM LEVEL A2 TO LEVEL B1 (Q613122)

From EU Knowledge Graph
Revision as of 16:26, 13 November 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): THE GENERAL OBJECTIVE OF THE INTERVENTION ÂUELLO TO DEVELOP IN THE VARIOUS ACTORS INVOLVED, NECESSARY LANGUAGE SKILLS AND INTERMEDIATE LEVEL KNOWLEDGE IN THE ENGLISH LANGUAGE USEFUL TO BE ABLE TO COMMUNICATE WITH FOREIGN CUSTOMERS SOLVING THE MOST COMMON ISSUES IN THE WORKING ENVIRONMENT IN THE PHARMACEUTICAL FIELD., translated_summary)
Jump to navigation Jump to search
Project Q613122 in Italy
Language Label Description Also known as
English
LEARNING ENGLISH LANGUAGE FROM LEVEL A2 TO LEVEL B1
Project Q613122 in Italy

    Statements

    0 references
    16,800.0 Euro
    0 references
    16,800.0 Euro
    0 references
    100.0 percent
    0 references
    29 October 2018
    0 references
    23 July 2019
    0 references
    29 March 2019
    0 references
    FARMACIA D'ARIA CLAUDIO
    0 references
    D'ARIA GIUSEPPINA
    0 references
    FARMACIA UVA DI MARIA CATERINA MOTTA & C. SNC
    0 references
    FARMACIA CONIGLIO SNC DELLA DOTT.SSA CONIGLIO RENATA
    0 references
    ELPIDA SRLS
    0 references
    FARMACIA SAN ROCCO
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    40°40'6.67"N, 16°36'5.72"E
    0 references
    L'OBIETTIVO GENERALE DELL'INTERVENTO ¿UELLO DI SVILUPPARE NEI VARI ATTORI COINVOLTI, COMPETENZE LINGUISTICHE NECESSARIE E CONOSCENZE DI LIVELLO INTERMEDIO NELLA LINGUA INGLESE UTILI PER POTER COMUNICARE CON CLIENTI STRANIERI RISOLVENDO LE QUESTIONI PI¿ COMUNI NELL'AMBIENTE DEL LAVORO IN AMBITO FARMACEUTICO. (Italian)
    0 references
    THE GENERAL OBJECTIVE OF THE INTERVENTION ÂUELLO TO DEVELOP IN THE VARIOUS ACTORS INVOLVED, NECESSARY LANGUAGE SKILLS AND INTERMEDIATE LEVEL KNOWLEDGE IN THE ENGLISH LANGUAGE USEFUL TO BE ABLE TO COMMUNICATE WITH FOREIGN CUSTOMERS SOLVING THE MOST COMMON ISSUES IN THE WORKING ENVIRONMENT IN THE PHARMACEUTICAL FIELD. (English)
    13 November 2020
    0 references

    Identifiers

    G15B18007490008
    0 references